ANGIOSCOPIC PREDICTION OF SUCCESSFUL DILATATION AND OF RESTENOSIS IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - SIGNIFICANCE OF YELLOW PLAQUE

被引:28
|
作者
ITOH, A
MIYAZAKI, S
NONOGI, H
DAIKOKU, S
HAZE, K
机构
[1] Division of Cardiology, National Cardiovascular Center, Suita, Osaka
[2] Division of Cardiology, National Cardiovascular Center, Suita, Osaka 565
[3] Department of Cardiology, Osaka City General Hospital, Miyakojimaku, Osaka, Osaka 534
关键词
CORONARY DISEASE; RESTENOSIS; ANGIOSCOPY; ANGIOPLASTY;
D O I
10.1161/01.CIR.91.5.1389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Coronary angiography has been used to assess the anatomy of coronary artery and intraluminal pathological changes. However, it has several limitations in its diagnostic quality and sensitivity in the detection of intraluminal details. Angioscopy has enabled coronary artery lumens to be visualized directly and fine intraluminal morphological changes to be detected. The information obtained by angioscopy is expected to provide new insights into the mechanisms and pathophysiology of transluminal coronary angioplasty. Methods and Results Forty-seven patients (39 men and 8 women) with stable angina were enrolled in the present study. Angioscopy was performed before and after angioplasty with a 0.68-mm angioscope with a double-guiding catheter system. The patients who were successfully evaluated by angioscopy were divided into two groups according to the color of the lesion: group 1, mainly yellow; and group 2, white. Angiographic, angioscopic, and clinical parameters in the two groups were compared. Detailed angioscopic findings were obtained in 36 of the 47 patients (77%) before percutaneous transluminal coronary angioplasty (PTCA) and in 24 of the 47 (51%) after PTCA. Yellow plaque were found in 13 of 36 (36%). Age, sex, presence of coronary risk factors, serum cholesterol level, and duration of angina showed no correlation with plaque color. The incidence rates of dissection and thrombi after angioplasty also were not different. Successful dilatation was achieved in 13 of 13 patients (100%) in group 1 and in 21 of 23 (91%) in group 2. The restenosis rate of group 1 was significantly lower than that in group 2 (16.7% versus 57.9%, P<.05). Cox proportional hazards model revealed that plaque color was the independent variable associated with restenosis after PTCA (P=.03). Conclusions The restenosis rate after successful balloon angioplasty differs, with the color of the target lesion being significantly higher in patients with solely white plaque. Therefore, angioscopic findings are highly predictive of restenosis.
引用
收藏
页码:1389 / 1396
页数:8
相关论文
共 50 条
  • [32] Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: The Probucol Angioplasty Restenosis Trial
    Yokoi, H
    Daida, H
    Kuwabara, Y
    Nishikawa, H
    Takatsu, F
    Tomihara, H
    Nakata, Y
    Kutsumi, Y
    Ohshima, S
    Nishiyama, S
    Seki, A
    Kato, K
    Nishimura, S
    Kanoh, T
    Yamaguchi, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) : 855 - 862
  • [33] Exercise echocardiography performed early and late after percutaneous transluminal coronary angioplasty for prediction of restenosis
    Hoffmann, R
    Lethen, H
    Flachskampf, FA
    Hanrath, P
    EUROPEAN HEART JOURNAL, 1995, 16 (12) : 1872 - 1879
  • [34] Restenosis after percutaneous transluminal angioplasty
    Ramaswami, G
    Dhanjil, S
    Nicolaides, AN
    Griffin, M
    Al-Kutoubi, A
    Tegos, T
    Wilkins, R
    Lewis, J
    Boolell, M
    Davies, M
    AMERICAN JOURNAL OF SURGERY, 1998, 176 (02): : 102 - 108
  • [35] Axial plaque redistribution as a mechanism of percutaneous transluminal coronary angioplasty
    Mintz, GS
    Pichard, AD
    Kent, KM
    Satler, LF
    Popma, JJ
    Leon, MB
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (05): : 427 - &
  • [36] Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty
    Roguin, A
    Hochberg, I
    Nikolsky, E
    Markiewicz, W
    Meisel, SR
    Hir, J
    Grenadier, E
    Beyar, R
    Levy, AP
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (03): : 330 - +
  • [37] Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty
    Watanabe, K
    Sekiya, M
    Ikeda, S
    Miyagawa, M
    Hashida, K
    AMERICAN HEART JOURNAL, 1996, 132 (01) : 23 - 29
  • [38] Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty
    Lee, YJ
    Daida, H
    Yokoi, H
    Miyano, H
    Takaya, J
    Sakurai, H
    Mokuno, H
    Yamaguchi, H
    JAPANESE HEART JOURNAL, 1996, 37 (03): : 327 - 332
  • [39] T lymphocyte activation and restenosis after percutaneous transluminal coronary angioplasty
    Osada, M
    Takeda, S
    Ogawa, R
    Komori, S
    Tamura, K
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (04): : 219 - 221
  • [40] PhotopheresisTherapeutic Potential in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty
    Emil Bisaccia
    Mark Palangio
    Joselyn Gonzalez
    Albert S. Klainer
    John S. Banas
    American Journal of Cardiovascular Drugs, 2003, 3 (1) : 43 - 51